This content is restricted.
Debate with AI #8 – Main cause of the AI’s error
Debate with AI
Before watching the video, vote:
The Expert
Adrián Mosquera Orgueira
Adrián Mosquera Orgueira is a specialist in Hematology and Hemotherapy at the University Hospital of Santiago de Compostela and holds a Doctorate in Medicine from the University of Santiago de Compostela. He currently leads the Computational Hematology and Genomics Group (GrHeco-Xen) at the Santiago Health Research Institute (IDIS), focusing on the applications of genomics and artificial intelligence in the field of precision medicine. This line aims to improve the prediction of hematological cancer response to available treatments, as well as the development of personalized therapies for hematological cancer. He is the co-author of dozens of research papers in recent years, including publications in high-impact journals in the Hematology sector such as Leukemia, Blood Cancer Journal, Hemasphere, and Cancers. Additionally, he is currently involved in several research projects in the field of various hematological neoplasms. Dr. Mosquera combines this research activity with his clinical practice at CHUS and with the dissemination of scientific knowledge.
Debate with AI #7 – Survival bias in health research
Debate with AI
Before watching the video, vote:
In the following video, a medical AI agent analyzes this question and explains its reasoning.
The Expert
Adrián Mosquera Orgueira
Adrián Mosquera Orgueira is a specialist in Hematology and Hemotherapy at the University Hospital of Santiago de Compostela and holds a Doctorate in Medicine from the University of Santiago de Compostela. He currently leads the Computational Hematology and Genomics Group (GrHeco-Xen) at the Santiago Health Research Institute (IDIS), focusing on the applications of genomics and artificial intelligence in the field of precision medicine. This line aims to improve the prediction of hematological cancer response to available treatments, as well as the development of personalized therapies for hematological cancer. He is the co-author of dozens of research papers in recent years, including publications in high-impact journals in the Hematology sector such as Leukemia, Blood Cancer Journal, Hemasphere, and Cancers. Additionally, he is currently involved in several research projects in the field of various hematological neoplasms. Dr. Mosquera combines this research activity with his clinical practice at CHUS and with the dissemination of scientific knowledge.
Debate with AI #6 – Drug with the most pleiotropic effects
Debate with AI
Before watching the video, vote:
In the following video, a medical AI agent analyzes this question and explains its reasoning.
The Expert
Adrián Mosquera Orgueira
Adrián Mosquera Orgueira is a specialist in Hematology and Hemotherapy at the University Hospital of Santiago de Compostela and holds a Doctorate in Medicine from the University of Santiago de Compostela. He currently leads the Computational Hematology and Genomics Group (GrHeco-Xen) at the Santiago Health Research Institute (IDIS), focusing on the applications of genomics and artificial intelligence in the field of precision medicine. This line aims to improve the prediction of hematological cancer response to available treatments, as well as the development of personalized therapies for hematological cancer. He is the co-author of dozens of research papers in recent years, including publications in high-impact journals in the Hematology sector such as Leukemia, Blood Cancer Journal, Hemasphere, and Cancers. Additionally, he is currently involved in several research projects in the field of various hematological neoplasms. Dr. Mosquera combines this research activity with his clinical practice at CHUS and with the dissemination of scientific knowledge.
Debate with AI #5 – Mortality Reduction
Debate with AI
Before watching the video, vote:
In the following video, a medical AI agent analyzes this question and explains its reasoning.
The Expert
Adrián Mosquera Orgueira
Adrián Mosquera Orgueira is a specialist in Hematology and Hemotherapy at the University Hospital of Santiago de Compostela and holds a Doctorate in Medicine from the University of Santiago de Compostela. He currently leads the Computational Hematology and Genomics Group (GrHeco-Xen) at the Santiago Health Research Institute (IDIS), focusing on the applications of genomics and artificial intelligence in the field of precision medicine. This line aims to improve the prediction of hematological cancer response to available treatments, as well as the development of personalized therapies for hematological cancer. He is the co-author of dozens of research papers in recent years, including publications in high-impact journals in the Hematology sector such as Leukemia, Blood Cancer Journal, Hemasphere, and Cancers. Additionally, he is currently involved in several research projects in the field of various hematological neoplasms. Dr. Mosquera combines this research activity with his clinical practice at CHUS and with the dissemination of scientific knowledge.
Debate with AI #4 – Historical error in medicine
Debate with AI
Before watching the video, vote:
In the following video, a medical AI agent analyzes this question and explains its reasoning.
The Expert
Adrián Mosquera Orgueira
Adrián Mosquera Orgueira is a specialist in Hematology and Hemotherapy at the University Hospital of Santiago de Compostela and holds a Doctorate in Medicine from the University of Santiago de Compostela. He currently leads the Computational Hematology and Genomics Group (GrHeco-Xen) at the Santiago Health Research Institute (IDIS), focusing on the applications of genomics and artificial intelligence in the field of precision medicine. This line aims to improve the prediction of hematological cancer response to available treatments, as well as the development of personalized therapies for hematological cancer. He is the co-author of dozens of research papers in recent years, including publications in high-impact journals in the Hematology sector such as Leukemia, Blood Cancer Journal, Hemasphere, and Cancers. Additionally, he is currently involved in several research projects in the field of various hematological neoplasms. Dr. Mosquera combines this research activity with his clinical practice at CHUS and with the dissemination of scientific knowledge.
Debate with AI #3 – Most deadly animal to humans
Debate with AI
Before watching the video, vote:
In the following video, a medical AI agent analyzes this question and explains its reasoning.
The Expert
Adrián Mosquera Orgueira
Adrián Mosquera Orgueira is a specialist in Hematology and Hemotherapy at the University Hospital of Santiago de Compostela and holds a Doctorate in Medicine from the University of Santiago de Compostela. He currently leads the Computational Hematology and Genomics Group (GrHeco-Xen) at the Santiago Health Research Institute (IDIS), focusing on the applications of genomics and artificial intelligence in the field of precision medicine. This line aims to improve the prediction of hematological cancer response to available treatments, as well as the development of personalized therapies for hematological cancer. He is the co-author of dozens of research papers in recent years, including publications in high-impact journals in the Hematology sector such as Leukemia, Blood Cancer Journal, Hemasphere, and Cancers. Additionally, he is currently involved in several research projects in the field of various hematological neoplasms. Dr. Mosquera combines this research activity with his clinical practice at CHUS and with the dissemination of scientific knowledge.
Debate with AI #1 – Disease with the greatest improvement in survival over the last 25 years
Debate with AI
Before watching the video, vote:
In the following video, a medical AI agent analyzes this question and explains its reasoning.
The Expert
Adrián Mosquera Orgueira
Adrián Mosquera Orgueira is a specialist in Hematology and Hemotherapy at the University Hospital of Santiago de Compostela and holds a Doctorate in Medicine from the University of Santiago de Compostela. He currently leads the Computational Hematology and Genomics Group (GrHeco-Xen) at the Santiago Health Research Institute (IDIS), focusing on the applications of genomics and artificial intelligence in the field of precision medicine. This line aims to improve the prediction of hematological cancer response to available treatments, as well as the development of personalized therapies for hematological cancer. He is the co-author of dozens of research papers in recent years, including publications in high-impact journals in the Hematology sector such as Leukemia, Blood Cancer Journal, Hemasphere, and Cancers. Additionally, he is currently involved in several research projects in the field of various hematological neoplasms. Dr. Mosquera combines this research activity with his clinical practice at CHUS and with the dissemination of scientific knowledge.
Debate with AI #2 – The most innovative treatment of the last 25 years
Debate with AI
Before watching the video, vote:
In the following video, a medical AI agent analyzes this question and explains its reasoning.
The Expert
Adrián Mosquera Orgueira
Adrián Mosquera Orgueira is a specialist in Hematology and Hemotherapy at the University Hospital of Santiago de Compostela and holds a Doctorate in Medicine from the University of Santiago de Compostela. He currently leads the Computational Hematology and Genomics Group (GrHeco-Xen) at the Santiago Health Research Institute (IDIS), focusing on the applications of genomics and artificial intelligence in the field of precision medicine. This line aims to improve the prediction of hematological cancer response to available treatments, as well as the development of personalized therapies for hematological cancer. He is the co-author of dozens of research papers in recent years, including publications in high-impact journals in the Hematology sector such as Leukemia, Blood Cancer Journal, Hemasphere, and Cancers. Additionally, he is currently involved in several research projects in the field of various hematological neoplasms. Dr. Mosquera combines this research activity with his clinical practice at CHUS and with the dissemination of scientific knowledge.
Podcast S2P10 – Multidisciplinary Pills
This content is restricted.
